 Responsible for driving Clover’s portfolio of specialty products’ long-term commercial success by shaping geographical expansion, go-to-market activities leveraging on advocacy, access and commercial strategies for Clover’s portfolio.
 Drive development and delivery of access and revenues for Clover’s portfolio across supra-national organizations and countries worldwide with P&L responsibility
 Ensure access and market readiness of Clover’s products through the development and launch

 Led launch and access readiness for key countries in Asia Pacific Takeda’s vaccine portfolio representing ~$500M commercial opportunity; drove key disruptive/innovative approaches for private market launches, partnered with institutions on access initiatives for vaccines, and created of market access roadmaps to support National Immunization Programs (NIPs)
 Established Takeda presence in vaccines through country capability and FTE plans, recruitment in key Wave 1 markets

 Developed global brand plan and asset strategy and commercialization and access plan for Takeda’s dengue vaccine including launch sequencing, go-to-market and market access road maps
 Led the global innovation program named ‘Drive for Five’ incremental sales-driven change initiative founded on principles of innovation and collaboration by establishing the operational guidelines, designing on-line platform. This global program was designed, developed and executed in less than 8 weeks.

Responsibilities include effective management of portfolio of Anti-infectives in terms of developing and executing brand plans and strategies to achieve brand sales and profit goals
Responsibilities included leading an internal consulting group with people management experience of 16 individuals to provide strategic guidance to marketing teams and senior leadership on resource allocation, promotion response measurement and sales force size and structure recommendations